The Chromatrap technology is patented in the USA, Australia, Japan, UK and China by parent company - Porvair. The collaboration with BioLegend covers access to Chromatrap spin columns and proprietary buffers for use in BioLegend's new ChIP-sequencing kits in all geographic territories.
For further information please visit
https://www.chromatrap.com or contact Chromatrap® now on support@chromatrap.com / +44-1978-666222.
Chromatrap® is a business unit of Porvair Sciences Ltd. with R&D and production laboratories based in the UK. Their extensive product range includes ChIP kits, DNA clean up kits and other innovative products for epigenetic research. Now cited in approaching thirty papers Chromatrap ChIP technology is rapidly becoming the method of choice for fast accurate ChIP assays.
BioLegend develops and manufactures highly recognized, world-class antibodies and reagents at an outstanding value to customers for biomedical research. Our broad product portfolio includes flow cytometry, cell biology, and biofunctional molecules for research in immunology, neuroscience, cancer, cell biology, stem cells, and more. Our aggressive product development program, accomplished through technology licensing, collaborations, and internal research and development, has produced a product offering of over 17,000 products, which have been collectively cited in over 25,000 peer-reviewed journals. BioLegend also offers a wide range of custom services including assay development, sample testing, and conjugation. BioLegend's reagents are supported by superior customer service and a quality management system dedicated to continuous improvement that is certified for ISO 9001:2008 and ISO 13485:2003.
A business unit of Porvair Sciences Ltd.